A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections

Autor: Aristika Dinaryanti, Yongki Iswandi Purnama, Herley Windo Setiawan, Shinta Karina Yuniati, Prastuti Asta Wulaningrum, Taufik Ismail, Tri Pudy Asmarawati, Igo Syaiful Ihsan, Nora Ertanti, Eryk Hendrianto, Yulistiani, Disca Sandyakala Purnama, Ike Rochmad, Brian Eka Rachman, Yuni Indrayani, Budiono, Purwaningsih, Erika Marfiani, Soroy Lardo, Mafidhatul Laely, Sri Wulandari, Andang Miatmoko, Dwi Setyawan, Pepy Dwi Endraswari, Muhammad Rabiul Fuadi, Deya Karsari, Purwati, Alfian Nur Rosyid, Nasronudin

Publikováno v: Biochemistry research international, 2021:6685921
Biochemistry Research International, Vol 2021 (2021)
Biochemistry Research International

Background. At the present time, COVID-19 vaccines are at the testing stage, and an effective treatment for COVID-19 incorporating appropriate safety measures remains the most significant obstacle to be overcome. A strategic countermeasure is, theref

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ed5f77c5e533f36b41918859aa6f4b1